brokerage recos sector report
Jump to
3592 Results Found
  • Emami Q4 PAT seen up 5.2% YoY to Rs 86.1 cr: Sharekhan Apr 13, 2021 07:32 PM IST

    Emami Q4 PAT seen up 5.2% YoY to Rs 86.1 cr: Sharekhan

    Net Sales are expected to increase by 26 percent Y-o-Y (down 28.1 percent Q-o-Q) to Rs 671.2 crore, according to Sharekhan.

  • Dabur India Q4 PAT seen up 22.7% YoY to Rs 365.5 cr: Sharekhan Apr 13, 2021 07:17 PM IST

    Dabur India Q4 PAT seen up 22.7% YoY to Rs 365.5 cr: Sharekhan

    Net Sales are expected to increase by 28.6 percent Y-o-Y (down 12.1 percent Q-o-Q) to Rs 2,398.1 crore, according to Sharekhan.

  • Colgate-Palmolive Q4 PAT seen up 12.9% YoY to Rs 223.1 cr: Sharekhan Apr 13, 2021 07:16 PM IST

    Colgate-Palmolive Q4 PAT seen up 12.9% YoY to Rs 223.1 cr: Sharekhan

    Net Sales are expected to increase by 15.5 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs 1,227.3 crore, according to Sharekhan.

  • Britannia Industries Q4 PAT seen up 6.5% YoY to Rs 396.7 cr: Sharekhan Apr 13, 2021 07:16 PM IST

    Britannia Industries Q4 PAT seen up 6.5% YoY to Rs 396.7 cr: Sharekhan

    Net Sales are expected to increase by 8.1 percent Y-o-Y (down 2.1 percent Q-o-Q) to Rs 3,100.1 crore, according to Sharekhan.

  • Bajaj Consumer Care Q4 PAT seen up 76.4% YoY to Rs 43.3 cr: Sharekhan Apr 13, 2021 07:16 PM IST

    Bajaj Consumer Care Q4 PAT seen up 76.4% YoY to Rs 43.3 cr: Sharekhan

    Net Sales are expected to increase by 39.3 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 244.4 crore, according to Sharekhan.

  • Asian Paints Q4 PAT seen up 65.4% YoY to Rs 794.5 cr: Sharekhan Apr 13, 2021 07:16 PM IST

    Asian Paints Q4 PAT seen up 65.4% YoY to Rs 794.5 cr: Sharekhan

    Net Sales are expected to increase by 27.8 percent Y-o-Y (down 12.7 percent Q-o-Q) to Rs 5,924.2 crore, according to Sharekhan.

  • Spandana Sphoorty Q4 PAT may dip 56.7% YoY to Rs 34 cr: Sharekhan Apr 13, 2021 06:46 PM IST

    Spandana Sphoorty Q4 PAT may dip 56.7% YoY to Rs 34 cr: Sharekhan

    Net Sales are expected to decrease by 7.2 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs 209 crore, according to Sharekhan.

  • Repco Home Finance Q4 PAT seen up 85.5% YoY to Rs 88 cr: Sharekhan Apr 13, 2021 06:45 PM IST

    Repco Home Finance Q4 PAT seen up 85.5% YoY to Rs 88 cr: Sharekhan

    Net Sales are expected to increase by 12.8 percent Y-o-Y (up 3.3 percent Q-o-Q) to Rs 157 crore, according to Sharekhan.

  • M&M Financials Q4 PAT seen up 162.7% YoY to Rs 580 cr: Sharekhan Apr 13, 2021 06:45 PM IST

    M&M Financials Q4 PAT seen up 162.7% YoY to Rs 580 cr: Sharekhan

    Net Sales are expected to increase by 5.4 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs 1,420 crore, according to Sharekhan.

  • LIC Housing Q4 PAT seen up 11% YoY to Rs 763 cr: Sharekhan Apr 13, 2021 06:45 PM IST

    LIC Housing Q4 PAT seen up 11% YoY to Rs 763 cr: Sharekhan

    Net Sales are expected to decrease by 8.7 percent Y-o-Y (up 17.2 percent Q-o-Q) to Rs 1,245 crore, according to Sharekhan.

  • L&T Finance Holding Q4 PAT seen up 3.5% YoY to Rs 398 cr: Sharekhan Apr 13, 2021 06:27 PM IST

    L&T Finance Holding Q4 PAT seen up 3.5% YoY to Rs 398 cr: Sharekhan

    Net Sales are expected to increase by 19.6 percent Y-o-Y (up 7.1 percent Q-o-Q) to Rs 1,857 crore, according to Sharekhan.

  • HDFC Q4 PAT seen up 19.4% YoY to Rs 2,770 cr: Sharekhan Apr 13, 2021 06:26 PM IST

    HDFC Q4 PAT seen up 19.4% YoY to Rs 2,770 cr: Sharekhan

    Net Sales are expected to increase by 14.8 percent Y-o-Y (down 0.7 percent Q-o-Q) to Rs 3,976 crore, according to Sharekhan.

  • Cholamandalam Invesment Q4 PAT seen up 1,055.6% YoY to Rs 493 cr: Sharekhan Apr 13, 2021 06:26 PM IST

    Cholamandalam Invesment Q4 PAT seen up 1,055.6% YoY to Rs 493 cr: Sharekhan

    Net Sales are expected to increase by 36.7 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 1,388 crore, according to Sharekhan.

  • Bajaj Finance Q4 PAT seen up 44.2% YoY to Rs 1,367 cr: Sharekhan Apr 13, 2021 06:26 PM IST

    Bajaj Finance Q4 PAT seen up 44.2% YoY to Rs 1,367 cr: Sharekhan

    Net Sales are expected to decrease by 5.4 percent Y-o-Y (up 5.7 percent Q-o-Q) to Rs 3,551 crore, according to Sharekhan.

  • TTK Prestige Q4 PAT seen up 161.3% YoY to Rs. 54.5 cr: ICICI Direct Apr 13, 2021 12:20 PM IST

    TTK Prestige Q4 PAT seen up 161.3% YoY to Rs. 54.5 cr: ICICI Direct

    Net Sales are expected to increase by 35.1 percent Y-o-Y (down 23.7 percent Q-o-Q) to Rs. 518.2 crore, according to ICICI Direct.

  • Trent Limited Q4 PAT seen up 1,185.7% YoY to Rs. 33.7 cr: ICICI Direct Apr 13, 2021 12:02 PM IST

    Trent Limited Q4 PAT seen up 1,185.7% YoY to Rs. 33.7 cr: ICICI Direct

    Net Sales are expected to increase by 12 percent Y-o-Y (up 11.6 percent Q-o-Q) to Rs. 809.5 crore, according to ICICI Direct.

  • Titan Company Q4 PAT seen up 68.5% YoY to Rs. 578.2 cr: ICICI Direct Apr 13, 2021 11:57 AM IST

    Titan Company Q4 PAT seen up 68.5% YoY to Rs. 578.2 cr: ICICI Direct

    Net Sales are expected to increase by 58.2 percent Y-o-Y (down 2.2 percent Q-o-Q) to Rs. 7,454 crore, according to ICICI Direct.

  • Bata India Q4 PAT may dip 16.7% YoY to Rs. 31.4 cr: ICICI Direct Apr 13, 2021 11:55 AM IST

    Bata India Q4 PAT may dip 16.7% YoY to Rs. 31.4 cr: ICICI Direct

    Net Sales are expected to decrease by 1 percent Y-o-Y (down 0.2 percent Q-o-Q) to Rs. 613.6 crore, according to ICICI Direct.

  • Avenue Supermarts Q4 PAT seen up 10.9% YoY to Rs. 300.9 cr: ICICI Direct Apr 13, 2021 11:50 AM IST

    Avenue Supermarts Q4 PAT seen up 10.9% YoY to Rs. 300.9 cr: ICICI Direct

    Net Sales are expected to increase by 18.4 percent Y-o-Y (down 1.8 percent Q-o-Q) to Rs. 7,407 crore, according to ICICI Direct.

  • Gland Pharma Q4 PAT seen up 17.3% YoY to Rs. 229 cr: Sharekhan Apr 12, 2021 09:14 PM IST

    Gland Pharma Q4 PAT seen up 17.3% YoY to Rs. 229 cr: Sharekhan

    Net Sales are expected to increase by 30 percent Y-o-Y (down 3.9 percent Q-o-Q) to Rs. 825.8 crore, according to Sharekhan.

  • Solara Active Pharma Q4 PAT seen up 223.6% YoY to Rs. 57.6 cr: Sharekhan Apr 12, 2021 09:14 PM IST

    Solara Active Pharma Q4 PAT seen up 223.6% YoY to Rs. 57.6 cr: Sharekhan

    Net Sales are expected to increase by 35.4 percent Y-o-Y (down 5.8 percent Q-o-Q) to Rs. 401.9 crore, according to Sharekhan.

  • Shilpa Medicare Q4 PAT may dip 72.3% YoY to Rs. 9.6 cr: Sharekhan Apr 12, 2021 09:03 PM IST

    Shilpa Medicare Q4 PAT may dip 72.3% YoY to Rs. 9.6 cr: Sharekhan

    Net Sales are expected to decrease by 15 percent Y-o-Y (down 2.2 percent Q-o-Q) to Rs. 187 crore, according to Sharekhan.

  • Strides Pharma Science Q4 PAT may dip 488.7% YoY to Rs. 72.3 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Strides Pharma Science Q4 PAT may dip 488.7% YoY to Rs. 72.3 cr: Sharekhan

    Net Sales are expected to increase by 31 percent Y-o-Y (down 2.6 percent Q-o-Q) to Rs. 810.3 crore, according to Sharekhan.

  • Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Abbott India Q4 PAT seen up 55.7% YoY to Rs. 172.8 cr: Sharekhan

    Net Sales are expected to increase by 4 percent Y-o-Y (down 8.8 percent Q-o-Q) to Rs. 999.6 crore, according to Sharekhan.

  • Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan Apr 12, 2021 09:02 PM IST

    Laurus Labs Q4 PAT seen up 366.3% YoY to Rs. 232.2 cr: Sharekhan

    Net Sales are expected to increase by 56.6 percent Y-o-Y (up 2 percent Q-o-Q) to Rs. 1,314.3 crore, according to Sharekhan.

Sections
ISO 27001 - BSI Assurance Mark